» Articles » PMID: 37009508

Clinical Features and Diagnostic Value of Metagenomic Next -generation Sequencing in Five Cases of Non-HIV Related Pneumonia in Children

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: (PJ) is an opportunistic pathogenic fungus, and PJ pneumonia (PJP) is a commonly problem in HIV-positive patients. While PJP is not caused by HIV, it generally advances rapidly and can quickly lead to severe respiratory failure. To improve pediatricians' understanding of the condition and aid early accurate diagnoses and therapy, we examined the clinical characteristics of five instances of non-HIV related PJP (NH-PJP) in children and the efficacy of metagenomic next-generation sequencing (mNGS) in its diagnosis.

Methods: From January 2020 to June 2022, five children with NH-PJP were admitted to the PICU of the First Affiliated Hospital of Zhengzhou University. We retrospectively summarize the clinical presentation, previous histories, routine laboratory findings, treatment, outcome of regression, and results of mNGS in these five children.

Results: Five male children between the ages of 11 months and 14 years had an acute onset on NH-PJP, three of the children had chest tightness after activity, shortness of breath and paroxysmal dry cough, - and two had high fever and dry cough. All five of the children had several flocculent high-density pictures in both lungs at the beginning of the disease, and lung auscultation revealed coarse breath sounds in both lungs, one of which was accompanied by a modest quantity of dry rales. PJ nuclear sequences were found in one patient and four patients' blood and alveolar lavage fluid. All five children were treated with Trimethoprim-sulfamethoxazole (TMP-SMX) in combination with Caspofungin and corresponding symptomatic treatment. Four patients were cured and one patient died.

Conclusion: Children commonly encounter an initial exposure to NH-PJP, which manifests as a high fever, dry cough, chest discomfort, dyspnea that worsens over time, fast disease progression, and a high death rate. The clinical presentation of children with PJ infection should be taken into consideration along with the results for diagnose. mNGS has higher sensitivity and a shorter detection period compared to identification of PJP.

Citing Articles

Risk factors for identifying pneumocystis pneumonia in pediatric patients.

Zhang C, Li Z, Chen X, Wang M, Yang E, Xu H Front Cell Infect Microbiol. 2024; 14():1398152.

PMID: 39507946 PMC: 11537976. DOI: 10.3389/fcimb.2024.1398152.


The efficacy of nebulized budesonide and ambroxol hydrochloride in treating pediatric community-acquired pneumonia and their impact on clinical characteristics and inflammatory markers.

Zhang X, Zhang X, Gu J, Zhang L, Yang R J Health Popul Nutr. 2024; 43(1):132.

PMID: 39192358 PMC: 11348777. DOI: 10.1186/s41043-024-00621-4.


Metagenomic next-generation sequencing promotes diagnosis and treatment of Pneumocystis jirovecii pneumonia in non-HIV infected children: a retrospective study.

Zhang Z, Liu T, Ming M, Shen M, Zhang Y, Chen H BMC Pulm Med. 2024; 24(1):338.

PMID: 38997717 PMC: 11241876. DOI: 10.1186/s12890-024-03135-1.


The diagnostic value of metagenomics next-generation sequencing in HIV-infected patients with suspected pulmonary infections.

Hou M, Wang Y, Yuan H, Zhang Y, Luo X, Xin N Front Cell Infect Microbiol. 2024; 14:1395239.

PMID: 38774626 PMC: 11106401. DOI: 10.3389/fcimb.2024.1395239.

References
1.
Sun R, Lv D, Xiao M, Zhang L, Xu J, Yu X . Diagnostic accuracy of the 1,3-beta-D-glucan test and lactate dehydrogenase for pneumocystis pneumonia in non-HIV patients. Sci Rep. 2021; 11(1):9226. PMC: 8085008. DOI: 10.1038/s41598-021-88729-z. View

2.
Dunbar A, Schauwvlieghe A, Algoe S, van Hellemond J, Reynders M, Vandecasteele S . Epidemiology of Pneumonia and (Non-)use of Prophylaxis. Front Cell Infect Microbiol. 2020; 10:224. PMC: 7243458. DOI: 10.3389/fcimb.2020.00224. View

3.
Mercier T, Guldentops E, Patteet S, Beuselinck K, Lagrou K, Maertens J . Beta-d-Glucan for Diagnosing Pneumonia: a Direct Comparison between the Wako β-Glucan Assay and the Fungitell Assay. J Clin Microbiol. 2019; 57(6). PMC: 6535610. DOI: 10.1128/JCM.00322-19. View

4.
Oladele R, Otu A, Richardson M, Denning D . Diagnosis and Management of Pneumocystis Pneumonia in Resource-poor Settings. J Health Care Poor Underserved. 2018; 29(1):107-158. DOI: 10.1353/hpu.2018.0010. View

5.
Bateman M, Oladele R, Kolls J . Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches. Med Mycol. 2020; 58(8):1015-1028. PMC: 7657095. DOI: 10.1093/mmy/myaa024. View